s100a4 anticorps (C-Term)
-
- Antigène Voir toutes s100a4 (S100A4) Anticorps
- s100a4 (S100A4) (S100 Calcium Binding Protein A4 (S100A4))
-
Épitope
- C-Term
-
Reactivité
- Humain
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp s100a4 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Fonction
- S100A4 / CAPL
- Séquence
- CNEFFEGFPD KQP
- Specificité
- Both variants (NP_002952.1, NP_062427.1) represent identical protein.
- Réactivité croisée
- Chien, Humain, Souris, Rat
- Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Classe de qualité
- Verified
- Immunogène
- Peptide with sequence CNEFFEGFPDKQP, from the C Terminus of the protein sequence according to NP_002952.1, NP_062427.1.
- Isotype
- IgG
- Top Product
- Discover our top product S100A4 Anticorps primaire
-
-
- Indications d'application
-
Immunohistochemistry: In paraffin embedded Human Small Intestine shows staining of lymphatic cells in the lamina propria. Recommended concentration: 1-2 μg/mL.
Western Blot: Approx 13 kDa band observed in Human Peripheral blood mononuclear cells lysates (calculated MW of 11.7 kDa according to NP_002952.1). Recommended concentration: 0.05-0.2 μg/mL. Primary incubation was 1 hour.
Peptide ELISA: antibody detection limit dilution 1:128000.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Minimize freezing and thawing.
- Stock
- -20 °C
- Stockage commentaire
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target." dans: Molecular & cellular proteomics : MCP, Vol. 12, Issue 12, pp. 3778-92, (2013) (PubMed).
: "
-
Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target." dans: Molecular & cellular proteomics : MCP, Vol. 12, Issue 12, pp. 3778-92, (2013) (PubMed).
-
- Antigène
- s100a4 (S100A4) (S100 Calcium Binding Protein A4 (S100A4))
- Autre désignation
- S100A4 (S100A4 Produits)
- Synonymes
- anticorps 18A2, anticorps 42A, anticorps CAPL, anticorps FSP1, anticorps MTS1, anticorps P9KA, anticorps PEL98, anticorps 42a, anticorps Capl, anticorps FSp1, anticorps Mts1, anticorps PeL98, anticorps metastasin, anticorps pk9a, anticorps S100A4, anticorps P9ka, anticorps RNP9KA, anticorps S100 calcium binding protein A4, anticorps S100 calcium-binding protein A4, anticorps S100A4, anticorps S100a4
- Sujet
- S100A4, CAPL, S100 calcium binding protein A4, 18A2, 42A, MTS1, P9KA, PEL98, S100 calcium binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog), S100 calcium-binding protein A4, S100 calcium-binding protein A4 (calcium pr
- ID gène
- 6275, 20198, 24615
- NCBI Accession
- NP_002952, NP_062427
- Pathways
- S100 Proteins
-